Hematology Diagnostics Market 2023 Emerging Industry Trends and Dynamics with Prominent Players Profiled by MRFR | Sysmex, Danaher, Nihon Kohden, Siemens, Abbott Laboratories, Boule Diagnostics, HORIBA

The Industry Report gives an unmistakable image of the Current Market Scenario which incorporates past and assessed future size concerning worth and volume, innovative headway, large scale practical and administering factors in the market.

Hematology is the branch of science that includes various in vitro diagnostic techniques like blood analysis, immunodiagnostics, flow cytometry, molecular diagnostics, histology, hemostasis, and cytology.

The increasing prevalence of blood disorders, technological advancements increase in the prevalence of genetic diseases, rise in hematological testing, growing blood transfusions and donations and increasing adoption of automated hematology analyzers are the key factors for the market to grow.

FREE SAMPLE REPORT AT https://www.marketresearchfuture.com/sample_request/6262

However, factors such as high cost of diagnostics, poor healthcare insurance coverage for diagnostic procedures and lack of awareness are expected to restrict the market growth during the forecast period.

Hematology Diagnostics Market - Top Industry Players Profiles

Sysmex (Japan)
Danaher (US)
Nihon Kohden (Japan)
Siemens (Germany)
Abbott Laboratories (US)
Boule Diagnostics (Sweden)
HORIBA (Japan)
Bio-Rad Laboratories (US)
BioSystems (Spain)
Diatron (Hungary)

Hematology Diagnostics Market - Growing Segment

The Global Hematology Diagnostics Market is segmented on the basis of product type, tests, and end-user. The hematology diagnostics market, by product type categorized into hematology analyzers, flow cytometers, and consumables.

Hematology analyzers category includes fully-automated hematology analyzers and semi-automated hematology analyzers. Consumables segment includes reagents, stains, controls & calibrators, and others.

The tests category is further segmented into anemia, hemoglobinopathy, leukemia/lymphoma phenotyping, hematology pathophysiology, complete blood count (CBC) and others.

On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, academic institutes, and others.  

Hematology Diagnostics Market – Competitive Landscape

The Americas is expected to dominate the hematology diagnostics market during the forecast period. The rise in the occurrence of blood disorders such as sickle cell anemia, thalassemia, leukemia and others drives the market in this region.

According to the Centers for Disease Control and Prevention (2016), 900,000 peoples are affected by venous thromboembolism each year in the U.S. This influences the market growth during the forecast period.

Europe (UK, Belgium, France, & the Netherlands) is second in the market owing to the increasing prevalence of blood disorder and growing healthcare expenditure.

BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH RESPECTIVE TABLES AND FIGURES AT https://www.marketresearchfuture.com/reports/hematology-diagnostics-market-6262

According to the   Health Economics Research Centre in 2015, Blood cancers (e.g., Hodgkin’s lymphoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia) are one of the top 10 most common forms of cancer and are responsible for approximately 100,000 deaths in Europe every year.

Asia-Pacific is expected to observe growth for the global hematology diagnostics market owing to increasing genetic blood disorders, rising geriatric population, and growing healthcare sector. 

According to the India Brand Equity Foundation healthcare sector is one of the largest sectors of India and is expected to reach US$ 372 billion by 2022. Thus, providing favorable backgrounds for the market to grow. The Middle East and Africa accounts for least share due to stringent government policies and low per capita income.

Major Points form Table of Content of Global Hematology Diagnostics Market

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Hematology Diagnostics Market, By Type

Chapter 7. Global Hematology Diagnostics Market, By Treatment

Chapter 8 Global Hematology Diagnostics Market, By End User

Chapter 9. Global Hematology Diagnostics Market, By Region

Chapter 10 Company Landscape

Chapter 11 Company Profiles

Chapter 12 MRFR Conclusion

Chapter 13 Appendix

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.